PTCH1 and nevoid basal cell carcinoma syndrome: It is also interesting to consider whether apart from the classical tumor suppressor ‘two-hit’ model, the ‘continuum model’ [56] that accounts for subtle dosage effects, ‘obligate haploinsufficiency’, is associated with the effect of PTCH1 tumor suppressor gene in BCNS.